Amneal Pharmaceuticals, Inc.·4

May 14, 4:44 PM ET

MEISTER PAUL M 4

4 · Amneal Pharmaceuticals, Inc. · Filed May 14, 2024

Insider Transaction Report

Form 4
Period: 2024-05-10
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2024-05-10+107,034727,692 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-05-10107,0340 total
    Class A Common Stock (107,034 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
  • [F2]On May 9, 2023 the reporting person was granted 107,034 restricted stock units vesting on May 10, 2024.

Documents

1 file
  • 4
    wk-form4_1715719430.xmlPrimary

    FORM 4